Summary of findings 2: PLD alone vs other conventional chemotherapy
The review found no eligible studies for this question.
- Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found